SCHEMBL24925458

SCHEMBL24925458

CC(C)(C)c1nccc(C(=O)C(=O)O)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 4/20 0.35
KDM5A P29375 2/20 0.35
KDM3A Q9Y4C1 2/20 0.35
KDM6B O15054 1/20 0.35
TET3 O43151 1/20 0.35
KDM4A O75164 1/20 0.35
BBOX1 O75936 1/20 0.35
MAPT P10636 1/20 0.35
KDM5C P41229 1/20 0.35
ASPH Q12797 1/20 0.35
KDM4D Q6B0I6 1/20 0.35
TET2 Q6N021 1/20 0.35
ALKBH5 Q6P6C2 1/20 0.35
KDM7A Q6ZMT4 1/20 0.35
KDM8 Q8N371 1/20 0.35
TET1 Q8NFU7 1/20 0.35
EGLN2 Q96KS0 1/20 0.35
FTO Q9C0B1 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2627832 0.85 KDM4E (0.49) KDM4EALDH1A1KDM5AKDM3AKDM6B
SCHEMBL31506349 0.85 KDM4E (0.49) KDM4EALDH1A1KDM5AKDM3AKDM6B
SCHEMBL3743806 0.84 KDM4E (0.47) KDM4EALDH1A1KDM5AKDM3AKDM6B
SCHEMBL13043849 0.81 ALDH1A1 (0.42) KDM4EALDH1A1KDM5AKDM3AKDM6B
SCHEMBL13043958 0.80 GABRP (0.35) KDM4EALDH1A1KDM5AKDM3AKDM6B
SCHEMBL3683998 0.80 SYK (0.41) KDM4EKDM5AKDM3AJMJD1CSYK
Lithium Ion SCHEMBL3743801 0.79 SYK (0.33) KDM4EALDH1A1KDM5AKDM3AKDM6B
SCHEMBL13044085 0.77 KDM4E (0.33) KDM4EALDH1A1KDM5AKDM3AKDM6B
SCHEMBL13078469 0.77 SYK (0.35) KDM4EALDH1A1KDM5AKDM3AKDM6B
SCHEMBL24925438 0.77 HDAC1 (0.42) KDM4EKDM5AKDM3AKDM4DJMJD1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230022696-A1 SMALL MOLECULE INHIBITORS OF AUTOPHAGY AND HISTONE DEACTYLASES AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230022696-A1 SMALL MOLECULE INHIBITORS OF AUTOPHAGY AND HISTONE DEACTYLASES AND USES THEREOF HDAC5, HDAC4, HDAC7 KDM4E 205/4885ALDH1A1 2087/4885KDM5A 108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.